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ABSTRACT 
Osteoporosis is a skeletal disease characterized by reduced bone strength 
and deterioration in bone microstructure, leading to increased risk of fragility 
fracture. Bone strength is mainly determined by bone mineral density (BMD). The 
variation in BMD is partly determined by genetic factors. An individual's risk of 
fracture is determined by the individual's genetic structure and environmental 
exposures. While several genetic variants associated with BMD have been 
identified, the contribution of these variants to fracture risk prediction has not been 
well-documented. In this thesis, I sought to (i) construct an osteogenomic profile 
from BMD-associated genetic variants; (ii) assess the association between the 
profile and fracture risk and bone loss; (iii) determine the clinical utility of the 
osteogenomic profile in terms of fracture risk assessment; and (iv) improve the 
accuracy of hip fracture prediction in postmenopausal women by using artificial 
neural network approach. 
The work in this thesis was based on the Dubbo Epidemiology Osteoporosis 
Study, which is designed as a population-based longitudinal prospective cohort 
investigation that involved more than 4000 men and women aged 60+years. The 
individuals had been followed up to 27 years. The incidence of fracture was 
ascertained during the follow-up period. A unique osteogenomic profile was 
constructed for each individual from 68 BMD-associated genetic variants. The 
osteogenomic profile was significantly associated with BMD, fracture risk, and 




model improved the prognostic performance over and above of traditional clinical 
risk factors models (age, gender, prior fracture, and history of fall). The area under 
the receiver operating characteristic curve for model with the osteogenomic profile 
was 71.1%, an increase of 0.5% compared with the model without the profile. 
More importantly, reclassification analysis showed that compared with the clinical 
risk factor (CRF) model, adding GRS resulted in 16% of individuals moving 
correctly from one risk category to another. In decision curve analysis, I found that 
for risk threshold greater than 15%, the osteogenomic profile could help reduce 
the number of unnecessary treatments. I also demonstrated that the predictive 
accuracy of fracture prediction using artificial neural network model was improved 
to 87% (AUC 0.94), which was significantly higher than that for the Cox's 
proportional hazards model (Accuracy 82%, AUC 0.85) or the Garvan model 
(Accuracy 83%, AUC 0.86). 
In conclusion, this thesis shows that an osteogenomic profile constructed 
from multiple BMD associated genetic variants is associated with fracture risk, 
and that the incorporation of osteogenomic profile could enhance the accuracy of 
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